Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Transcenta Reports Immuno-PET Diagnoses CLDN18.2 Levels in Gastrointestinal Tumors

publication date: Mar 3, 2023

Suzhou Transcenta published study results in the Journal of Pharmaceutical Analysis from its CLDN18.2-targeting Immuno-PET probe for non-invasive imaging in gastrointestinal tumors. Because CLDN18.2 expression level is correlated with drug efficacy, the level is critical for using CLDN18.2-targeted therapies. Currently, the main detection tool for CLDN18.2 protein expression is immunohistochemistry, which is invasive and requires an endoscopic biopsy. Transcenta is developing Osemitamab, a high affinity anti-CLDN18.2 monoclonal antibody, in eight Phase I and II trials in China and the US for oncology indications. More details....

Stock Symbol: (HK: 06628)

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here